RenewCO₂ | $5,000,000 | (Sep 3, 2025)
Edgehax (formerly Bharat Pi) | $157,736 | (Sep 3, 2025)
Sensorium Therapeutics
United States
- Boston, Massachusetts
- 03/09/2025
- Series A
- $25,000,000
Founded by world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University, Sensorium Therapeutics is a biotechnology company leveraging cutting-edge chemistry, neuroscience, and machine learning to develop nature-derived psychoactive medicines for mental health. Inspired by the real-world human benefits of plants and fungi, Sensorium’s groundbreaking Biodynamic Discovery Platform leverages cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can deliver transformational benefits to patients around the world. Visit sensorium.bio to learn more.
- Industry Biotechnology Research
- Website https://www.sensorium.bio/
- LinkedIn https://www.linkedin.com/company/sensorium-therapeutics/
Related People
Jacob HookerFounder
United States -
Cambridge, Massachusetts
My mission is to transform the way we treat brain and mental health conditions—bringing bold science to bear on one of the most urgent challenges of our time. Deeply trained as a scientist and shaped by academia, I’ve built a career turning ideas into action, leading efforts that push the boundaries of what’s possible in neuroscience and therapeutic innovation. As a biotech entrepreneur and executive, I work at the intersection of science and strategy to build ventures with real-world impact. I’m driven by a vision of mental health care that’s more effective, more human, and deeply grounded in science.
Leo AI | $9,700,000 | (Sep 3, 2025)
Obita | $10,000,000 | (Sep 3, 2025)
Cyted Health | $44,000,000 | (Sep 3, 2025)
Predoc | $30,000,000 | (Sep 3, 2025)
Tangany | $11,627,636 | (Sep 3, 2025)
Axelyf | $2,600,000 | (Sep 3, 2025)
Professional.me | $3,100,000 | (Sep 3, 2025)
LEAFYBUS | $4,100,000 | (Sep 3, 2025)